PURPOSE: To develop and test a novel signal enhancement method for optical coherence tomography (OCT) images based on the high dynamic range (HDR) imaging concept. METHODS: Three virtual channels, which represent low, medium, and high signal components, were produced for each OCT signal dataset. The dynamic range of each signal component was normalized to the full gray scale range. Finally, the three components were recombined into one image using various weights. Fourteen eyes of 14 healthy volunteers were scanned multiple times using time-domain (TD)-OCT before and while preventing blinking in order to produce a wide variety of signal strength (SS) images on the same eye scanned on the same day. For each eye, a pair of scans with the highest and lowest SS with successful retinal nerve fiber layer (RNFL) segmentation was selected to test the signal enhancement effect. In addition, spectral-domain (SD)-OCT images with poor signal qualities were also processed. RESULTS: Mean SS of good and poor quality scans were 9.0 ± 1.1 and 4.4 ± 0.9, respectively. TD-OCT RNFL thickness showed significant differences between good and poor quality scans on the same eye (mean difference 11.9 ± 6.0 μm, P < 0.0001, paired t-test), while there was no significant difference after signal enhancement (1.7 ± 6.2 μm, P = 0.33). However, HDR had weaker RNFL compensation effect on images with SS less than or equal to 4, while it maintained good compensation effect on images with SS greater than 4. Successful signal enhancement was also confirmed subjectively on SD-OCT images. CONCLUSION: The HDR imaging successfully restored OCT signal and image quality and reduced RNFL thickness differences due to variable signal level to the level within the expected measurement variability. This technique can be applied to both TD- and SD-OCT images.
PURPOSE: To develop and test a novel signal enhancement method for optical coherence tomography (OCT) images based on the high dynamic range (HDR) imaging concept. METHODS: Three virtual channels, which represent low, medium, and high signal components, were produced for each OCT signal dataset. The dynamic range of each signal component was normalized to the full gray scale range. Finally, the three components were recombined into one image using various weights. Fourteen eyes of 14 healthy volunteers were scanned multiple times using time-domain (TD)-OCT before and while preventing blinking in order to produce a wide variety of signal strength (SS) images on the same eye scanned on the same day. For each eye, a pair of scans with the highest and lowest SS with successful retinal nerve fiber layer (RNFL) segmentation was selected to test the signal enhancement effect. In addition, spectral-domain (SD)-OCT images with poor signal qualities were also processed. RESULTS: Mean SS of good and poor quality scans were 9.0 ± 1.1 and 4.4 ± 0.9, respectively. TD-OCT RNFL thickness showed significant differences between good and poor quality scans on the same eye (mean difference 11.9 ± 6.0 μm, P < 0.0001, paired t-test), while there was no significant difference after signal enhancement (1.7 ± 6.2 μm, P = 0.33). However, HDR had weaker RNFL compensation effect on images with SS less than or equal to 4, while it maintained good compensation effect on images with SS greater than 4. Successful signal enhancement was also confirmed subjectively on SD-OCT images. CONCLUSION: The HDR imaging successfully restored OCT signal and image quality and reduced RNFL thickness differences due to variable signal level to the level within the expected measurement variability. This technique can be applied to both TD- and SD-OCT images.
Authors: Lelia A Paunescu; Joel S Schuman; Lori Lyn Price; Paul C Stark; Siobahn Beaton; Hiroshi Ishikawa; Gadi Wollstein; James G Fujimoto Journal: Invest Ophthalmol Vis Sci Date: 2004-06 Impact factor: 4.799
Authors: Michelle L Gabriele; Gadi Wollstein; Hiroshi Ishikawa; Larry Kagemann; Juan Xu; Lindsey S Folio; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2011-04-14 Impact factor: 4.799
Authors: J S Schuman; M R Hee; A V Arya; T Pedut-Kloizman; C A Puliafito; J G Fujimoto; E A Swanson Journal: Curr Opin Ophthalmol Date: 1995-04 Impact factor: 3.761
Authors: J S Schuman; M R Hee; C A Puliafito; C Wong; T Pedut-Kloizman; C P Lin; E Hertzmark; J A Izatt; E A Swanson; J G Fujimoto Journal: Arch Ophthalmol Date: 1995-05
Authors: Chieh-Li Chen; Hiroshi Ishikawa; Yun Ling; Gadi Wollstein; Richard A Bilonick; Juan Xu; James G Fujimoto; Ian A Sigal; Larry Kagemann; Joel S Schuman Journal: Invest Ophthalmol Vis Sci Date: 2013-11-05 Impact factor: 4.799
Authors: Emily K Swingle; Andrew Lang; Aaron Carass; Omar Al-Louzi; Shiv Saidha; Jerry L Prince; Peter A Calabresi Journal: Proc SPIE Int Soc Opt Eng Date: 2015
Authors: Chieh-Li Chen; Hiroshi Ishikawa; Gadi Wollstein; Richard A Bilonick; Larry Kagemann; Joel S Schuman Journal: Transl Vis Sci Technol Date: 2017-02-28 Impact factor: 3.283